Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,758,587
+$11,803,520 QoQ
Shares Held
835,504
+29.3% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 230 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Derivatives in RCUS
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$37,760
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. RCUS ranks #73 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in RCUS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,758,587 | 835,504 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,955,067 | 646,068 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $23,849,490 | 1,000,818 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,506,620 | 1,360,781 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,050,617 | 497,619 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,974,831 | 251,571 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,384,557 | 160,145 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,154,558 | 140,913 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,155,378 | 141,522 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $37,760 | 2,000 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $2,823,539 | 149,552 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,149,435 | 164,892 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $38,200 | 2,000 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $3,460,955 | 192,811 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $35,900 | 2,000 | Put | Defined | 2023-11-14 | |
| 2023-06-30 | $3,818,704 | 188,021 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,961,734 | 1,149,218 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,874,746 | 139,011 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,910,316 | 149,477 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,077,574 | 81,988 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,338,268 | 137,461 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,944,690 | 97,472 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,394,521 | 68,670 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,010,170 | 36,787 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $899,036 | 32,017 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $944,864 | 36,397 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $505,937 | 29,518 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $914,017 | 36,945 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $288,022 | 20,751 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||